Versant Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Hold	0	–	–	–	2039
2024 Q2	–	Sell	-83	Closed	-$609	–	1970
2024 Q1	$609	Hold	83	–	–	﹤0.01%	1652
2023 Q4	$310	Buy	+83	New	+$310	﹤0.01%	1780